Median overall survival, a secondary endpoint, reached nearly 3.5 years with Johnson & Johnson's RYBREVANT® plus LAZCLUZE® in atypical EGFR-mutated disease Consistent ...
Regulated cell death (RCD) comprises a diverse and expanding set of molecularly defined processes, such as apoptosis, necroptosis, ferroptosis, and ...
Researchers have demonstrated a promising new approach to stopping pancreatic cancer before it starts, using experimental drugs to eliminate microscopic precancerous lesions in the pancreas.
Initiation of a Phase I/IIa first-in-human trial for GLIX1 in glioblastoma (GBM) was announced, with the first patient dosed at NYU Langone Health; two additional academic centers (Northwestern ...
A cancer-killing virus has stopped pancreatic tumours from growing and spreading in three people in an initial safety trial, ...
Our scientists are accelerating research by looking to improve anti-tumor immune response, targeting specific cancer cells and helping inhibit cancer growth.
Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors ...
The breakthrough at Columbia University lays the groundwork for future clinical studies aimed at developing new treatments.
CEO Abizer Gaslightwala highlights promising ASCO data demonstrating synergy of AKTX-101 with adagasrib in KRAS-driven cancers TAMPA, Fla. and LONDON, (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc ...
We are delighted to receive this Horizon Europe grant, which is a further validation of both our scientific approach ...
Researchers found that lowering MHC I can expose cancerous or foreign cells to CD4+ T cell attack, reshaping assumptions ...
During animal cell division, a highly synchronized and tightly regulated dance of chromosomes takes place, ensuring the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results